Health / Medical Topics

    CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine

    A plasmid vaccine encoding wild type human carcinoembryonic antigen (CEA) fused to a tetanus toxoid T helper epitope, with potential antineoplastic activity. Upon vaccination and subsequent intradermal electroporation, CEA/tetanus toxoid T helper epitope fusion protein-expressing DNA plasmid vaccine may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against CEA-expressing tumor cells. CEA, a tumor associated antigen, is overexpressed in a variety of cancer cell types. The tetanus toxoid helper peptide epitope, obtained from the bacterial Clostridium tetani toxoid, binds to class II MHC molecules and increases the helper T-cell response thereby inducing an increased and long-term immune response. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Autologous human dendritic cells pulsed with RNA encoding the carcinoembryonic antigen (CEA) are being studied for possible use in the treatment of…
    A small piece of a tumor marker called carcinoembryonic antigen (CEA). CEA may be found in the blood of people who have…
    Members of the CEA family consist of a single N domain, with structural similarity to the immunoglobulin variable domains, followed by a…
    Members of the CEA Family Gene encode the members of the CEA Family Protein, which consist of a single N domain, with…
    A laboratory test that measures the level of carcinoembryonic antigen (CEA) in the blood. An increased amount of CEA may be found…
    A substance that may be found in the blood of people who have colon cancer, other types of cancer or diseases, or…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact